Fundraising Fox
Verrica
NASDAQ: VRCAWest Chester, US · Founded 2013 · 87 employees on LinkedIn · 2 known investors
Find your way into Verrica
Sign up to see every warm intro you have to Verrica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Verrica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma. Its products serve dermatology prescribers, payers, and patients, with a lead drug-device combination based on topical cantharidin.
Founders & leadership
Board
Investors · 2
How we know: OrbiMed's portfolio page · the S-1 prospectus · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$77.5M disclosed across 4 of 5 rounds · 1900–2025
▶$50MraisedDec 2025 · 21 investors · PharmaceuticalsRule 506(b)
- Mark PrygockiDirector
- Noah RosenbergExecutive Officer
- Diem NguyenDirector
- John KirbyExecutive Officer
- Gavin CorcoranDirector
- Jayson RiegerExecutive Officer, Director
- Paul B. ManningDirector
- David ZawitzExecutive Officer
- Lawrence EichenfieldDirector
- Sean StalfortDirector
- Offering amount
- $50M
- Amount sold
- $50M
- Sales commissions
- $500.2K
- Placement agents
- TD Securities (USA) LLC
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedFeb 2018 · 2 investors · PharmaceuticalsRule 506(b)
- Glenn OclassenDirector, Promoter
- Joseph BonaccorsoExecutive Officer
- Sean StalfortDirector, Promoter
- Ted WhiteExecutive Officer
- Paul ManningDirector, Promoter
- Anthony CavalloExecutive Officer
- James C. ReebalsExecutive Officer, Promoter
- Matthew DavidsonExecutive Officer, Director, Promoter
- Jayson RiegerExecutive Officer, Director, Promoter
- Offering amount
- $21M
- Amount sold
- $20M
- Minimum investment
- $25K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$5MraisedDec 2017 · 1 investors · PharmaceuticalsRule 506(b)
- Sean StalfortDirector, Promoter
- Matthew DavidsonExecutive Officer, Director, Promoter
- Paul ManningExecutive Officer, Director, Promoter
- James C. ReebalsExecutive Officer, Promoter
- Jayson RiegerExecutive Officer, Director, Promoter
- Glenn OclassenDirector, Promoter
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.4MraisedDec 2015 · 14 investors · PharmaceuticalsRule 506(b)
- Matthew DavidsonExecutive Officer, Director
- Jayson RiegerDirector
- Glenn OclassenDirector
- Sean StalfortDirector
- Paul ManningDirector
- Amount sold
- $2.4M
- Sales commissions
- $52.5K
- Placement agents
- IMS Health Capital, Inc.
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
In the news
Frequently asked questions
- What does Verrica do?
- Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma. Its products serve dermatology prescribers, payers, and patients, with a lead drug-device combination based on topical cantharidin.
- Who are Verrica's investors?
- Verrica's investors include OrbiMed, PBM Capital.
- How much funding has Verrica raised?
- Verrica has disclosed $77.5M raised across 4 of its 5 known rounds.
- Where is Verrica headquartered?
- Verrica is headquartered in West Chester, US.